Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 37,509 | 23,787 | 23,278 | 23,861 | 22,903 |
| Marketable Securities | 75,260 | 103,639 | 118,612 | 68,139 | 66,755 |
| Receivables | 7,390 | 6,490 | 7,162 | 8,712 | 11,098 |
| TOTAL | $123,836 | $138,362 | $154,588 | $106,878 | $106,779 |
| Non-Current Assets | |||||
| PPE Net | 17,486 | 18,320 | 18,471 | 15,018 | 9,804 |
| Investments And Advances | 13,775 | 11,395 | 11,497 | 17,952 | 17,471 |
| Intangibles | 16,119 | 16,523 | 16,927 | 17,331 | 17,736 |
| Other Non-Current Assets | 2,449 | 2,639 | 2,197 | 1,674 | 1,525 |
| TOTAL | $49,829 | $48,877 | $49,092 | $51,976 | $46,535 |
| Total Assets | $173,665 | $187,239 | $203,680 | $158,853 | $153,314 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,124 | 24,206 | 23,310 | 17,325 | 14,995 |
| Accrued Expenses | 8,429 | 8,612 | 7,920 | 7,189 | 5,910 |
| Other current liabilities | 750 | 361 | 940 | 1,364 | 1,051 |
| TOTAL | $51,375 | $35,405 | $33,364 | $27,382 | $40,003 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 25,073 | 2,227 | 1,193 | 1,504 | 18,047 |
| TOTAL | $9,195 | $9,345 | $8,197 | $7,942 | $7,366 |
| Total Liabilities | $60,570 | $44,751 | $41,561 | $35,324 | $47,369 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 7,577 | 7,531 | 7,522 | 7,516 | 6,216 |
| Common Shares | 91 | 90 | 90 | 78 | 75 |
| Retained earnings | -555,476 | -523,356 | -501,850 | -467,716 | -458,237 |
| Other shareholders' equity | -365 | -21 | 656 | 1,277 | 878 |
| TOTAL | $113,095 | $142,489 | $162,119 | $123,530 | $105,945 |
| Total Liabilities And Equity | $173,665 | $187,239 | $203,680 | $158,853 | $153,314 |